Zephyrnet Logo

[MeMed in GlobeNewswire] Maimonides Medical Center adopts revolutionary technology that quickly distinguishes bacterial and viral infections

Date:

(Brooklyn, NY) – Today, Maimonides Medical Center announced a landmark agreement with MeMed, an Israel-based medical technology firm, for the adoption of MeMed BV, a new, FDA-approved, cutting-edge test that distinguishes whether a patient is suffering from a bacterial or viral infection within 15 minutes.

Read more here.

The post [MeMed in GlobeNewswire] Maimonides Medical Center adopts revolutionary technology that quickly distinguishes bacterial and viral infections appeared first on OurCrowd Blog.

spot_img

Latest Intelligence

spot_img